MedDataX Logo

Peripheral Arteriopathy Rate In Stroke

NCT ID: NCT00794066

Last Updated: 2017-10-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-08-31

Study Completion Date

2017-10-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose:

To assess the prevalence of peripheral arterial disease (PAD) in acute stroke patients.

Interventions:

Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).

Design:

Prospective, open, cohort study.

Study size planned:

1500\.

Follow-up duration:

3 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Artery Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

PAD Stroke ICH prevalence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

TIA

measuring the ankle brachial index

Intervention Type PROCEDURE

Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).

2

Ischemic stroke

measuring the ankle brachial index

Intervention Type PROCEDURE

Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).

3

Hemorrhagic stroke

measuring the ankle brachial index

Intervention Type PROCEDURE

Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

measuring the ankle brachial index

Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All consecutive adult patients with acute ischemic or hemorrhagic stroke.

Exclusion Criteria

* Congestive heart failure.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Erlangen-Nürnberg Medical School

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stefan Schwab, MD

Role: STUDY_DIRECTOR

Head of the Department of Neurology, University of Erlangen, Germany

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Neurology, University of Erlangen, Germany

Erlangen, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PARIS-Study2009

Identifier Type: -

Identifier Source: org_study_id